Osman Asghar Mirza (Osman Mirza)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Benign Prostatic Hyperplasia

Structural Basis

Crystal Structure

Top Venues

ACS medicinal chemistry letters

The FEBS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Agnese C Pippione, Chiara Vigato, Cristina Tucciarello, Samrina Hussain, Edoardo Salladini, Ha H Truong, Niel M Henriksen, Gaia Vanzetti, Giorgia Giordano, Daniele Zonari, Osman Asghar Mirza, Karla A Frydenvang, Ymera Pignochino, Simonetta Oliaro-Bosso, Donatella Boschi, Marco Lucio Lolli
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications. ACS medicinal chemistry letters 15 (8) (2024)
Agnese C Pippione, Chiara Vigato, Cristina Tucciarello, Samrina Hussain, Edoardo Salladini, Ha H Truong, Niel M Henriksen, Gaia Vanzetti, Giorgia Giordano, Daniele Zonari, Osman Asghar Mirza, Karla A Frydenvang, Ymera Pignochino, Simonetta Oliaro-Bosso, Donatella Boschi, Marco Lucio Lolli
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications. ACS medicinal chemistry letters 15 (8) (2024)
Aqsa Shaheen, Fouzia Ismat, Mazhar Iqbal, Abdul Haque, Zaheer Ul Haq, Osman Asghar Mirza, Rita De Zorzi, Thomas Walz, Moazur Rahman
Characterization of the multidrug efflux transporter styMdtM from Salmonella enterica serovar Typhi. Proteins 89 (9) (2021)
Christian Krintel, Jerzy Dorosz, Andreas Haahr Larsen, Thor Seneca Thorsen, Raminta Venskutonytė, Osman Asghar Mirza, Michael Gajhede, Thomas Boesen, Jette Sandholm Kastrup
Binding of a negative allosteric modulator and competitive antagonist can occur simultaneously at the ionotropic glutamate receptor GluA2. The FEBS journal 288 (3) (2020)